Groundbreaking study reveals most effective adjunctive drug for Parkinson’s disease Post author: Post published:October 23, 2023 Post category:uncategorized The efficacy, tolerability, and safety of various anti-Parkinson’s drugs. You Might Also Like Evolocumab fails to reduce vein graft disease after coronary artery bypass surgery September 3, 2025 Group prenatal care improves health outcomes for mothers and babies July 31, 2025 Scientists uncover genetic secrets of Staphylococcus aureus survival in humans January 13, 2025